Skip to search boxSkip to navigationSkip to main content

Society of Gynecologic Oncology recommendations for fellowship education during the COVID-19 pandemic and beyond: Innovating programs to optimize trainee success

  • J. Stuart Ferriss(corresponding author)
    ,
  • Steve Rose
    ,
  • ,
  • Renata Urban
    ,
  • Ryan Spencer
    ,
  • Shitanshu Uppal
*Corresponding author for this work
  • Johns Hopkins University
    ,
  • University of Wisconsin-Madison
    ,
  • ,
  • University of Washington
    ,
  • University of Michigan, Ann Arbor
    ,
  • University of Miami
Scholary Output:
Contribution to journal
Review article
Peer-review

Open access

Abstract

In approximately ten months' time, the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected over 34 million people and caused over one million deaths worldwide. The impact of this virus on our health, relationships, and careers is difficult to overstate. As the economic realities for academic medical centers come into focus, we must recommit to our core missions of patient care, education, and research. Fellowship education programs in gynecologic oncology have quickly adapted to the “new normal” of social distancing using video conferencing platforms to continue clinical and didactic teaching. United in a time of crisis, we have embraced systemic change by developing and delivering collaborative educational content, overcoming the limitations imposed by institutional silos. Additional innovations are needed in order to overcome the losses in program surgical volume and research opportunities. With the end of the viral pandemic nowhere in sight, program directors can rethink how education is best delivered and potentially overhaul aspects of fellowship curriculum and content. Similarly, restrictions on travel and the need for social distancing has transformed the 2020 fellowship interview season from an in-person to a virtual experience. During this time of unprecedented and rapid change, program directors should be particularly mindful of the needs and health of their trainees and consider tailoring their educational experiences accordingly.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 271-278 (8 pages)

Journal (Volume, Issue Number)

Gynecologic Oncology (Volume 160, Issue 1)

Publication milestones

  • Published - 01/2021

Publication status

Published - 01/2021

ISSN

0090-8258

Publication IDs

  • Scopus: 85092604831
  • PubMed: 33077260

Publication metrics

Metrics

SciVal
Author count
9
SciVal
Paper percentile
81
Scopus
citations
Fractional count
1
Fractional count
0.11
Fractional count
8
Fractional count
0.89
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
6
Social media
11
Captures
146

Funding Details

RU reports royalties from UpToDate, CW reports research funding from Merck and advisory board participation with AstraZeneca and Genentech. All other authors report no relevant competing interests.
FunderFunding numbers
Merck
-